Why the study?
Does propranolol alter systemic and pulmonary blood transit time dispersion in healthy volunteers?
Does propranolol alter systemic and pulmonary blood transit time dispersion in healthy volunteers?
Beta-adrenergic blockade with propranolol significantly decreases cardiac output and increases the heterogeneity of blood transit times in both systemic and pulmonary circulations in healthy volunteers.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for beta-blockade effects on circulatory heterogeneity; leaves open relevance to patients.
Summary Knowledge of factors influencing the heterogeneity of blood transit times is important in cardiovascular physiology. The aim of the study was to investigate the effect of beta‐adrenergic blockade on blood transit time dispersion in awake, anxious volunteers. Recirculatory modelling of the disposition of intravascular markers using parametric forms for transit time distributions, such as the inverse G aussian distribution, provides the opportunity to estimate the systemic and pulmonary transit time dispersion in vivo . The latter is determined by the flow heterogeneity in the microcirculatory network. Using this approach, we have analysed indocyanine green ( ICG ) disposition data obtained in four subjects by frequent early arterial blood sampling before and after beta‐adrenergic blockade by propranolol. Propranolol decreased cardiac output from 9·3 ± 2·8 l min −1 to 3·5 ± 0·47 l min −1 ( P <0·05). This reduction was accompanied by a 4·5 ± 0·6‐fold and 2·1 ± 0·3‐fold increase ( P <0·001) in the relative dispersion (dimensionless variance) of blood transit times through the systemic and pulmonary circulation, respectively.
No takes yet. Share an insight, caveat, or question.
Weiß et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: